JP2024514709A5 - - Google Patents
Info
- Publication number
- JP2024514709A5 JP2024514709A5 JP2023565154A JP2023565154A JP2024514709A5 JP 2024514709 A5 JP2024514709 A5 JP 2024514709A5 JP 2023565154 A JP2023565154 A JP 2023565154A JP 2023565154 A JP2023565154 A JP 2023565154A JP 2024514709 A5 JP2024514709 A5 JP 2024514709A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- acceptable salt
- tautomer
- stereoisomer
- compound according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025196737A JP2026020230A (ja) | 2021-04-22 | 2025-11-17 | 複素環式化合物及びその使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163178309P | 2021-04-22 | 2021-04-22 | |
| US63/178,309 | 2021-04-22 | ||
| PCT/US2022/026059 WO2022226383A1 (en) | 2021-04-22 | 2022-04-22 | Heterocyclic compounds and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025196737A Division JP2026020230A (ja) | 2021-04-22 | 2025-11-17 | 複素環式化合物及びその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024514709A JP2024514709A (ja) | 2024-04-02 |
| JP2024514709A5 true JP2024514709A5 (https=) | 2025-04-24 |
| JP7781391B2 JP7781391B2 (ja) | 2025-12-08 |
Family
ID=83723210
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023565154A Active JP7781391B2 (ja) | 2021-04-22 | 2022-04-22 | 複素環式化合物及びその使用 |
| JP2025196737A Pending JP2026020230A (ja) | 2021-04-22 | 2025-11-17 | 複素環式化合物及びその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025196737A Pending JP2026020230A (ja) | 2021-04-22 | 2025-11-17 | 複素環式化合物及びその使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US12054475B2 (https=) |
| EP (1) | EP4326696A4 (https=) |
| JP (2) | JP7781391B2 (https=) |
| KR (2) | KR20260022493A (https=) |
| CN (1) | CN117897370A (https=) |
| AU (1) | AU2022262654A1 (https=) |
| CA (1) | CA3213692A1 (https=) |
| IL (2) | IL324964A (https=) |
| MX (1) | MX2023012435A (https=) |
| WO (1) | WO2022226383A1 (https=) |
| ZA (1) | ZA202309153B (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112638881B (zh) | 2018-07-31 | 2025-01-07 | 普林斯顿大学托管委员会 | 用于治疗转移性和化疗耐受性癌症的四氢喹啉衍生物 |
| WO2021151062A1 (en) * | 2020-01-24 | 2021-07-29 | The Trustees Of Princeton Univeristy | Heterocyclic compounds and uses thereof |
| IL324964A (en) | 2021-04-22 | 2026-01-01 | Kayothera Inc | Modified heterocycles as aldehyde dehydrogenase inhibitors |
| CN116120316B (zh) * | 2022-12-29 | 2025-12-05 | 渭南瑞联制药有限责任公司 | 一种氮杂三环抗菌化合物的合成方法 |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60126270A (ja) | 1983-12-14 | 1985-07-05 | Otsuka Pharmaceut Co Ltd | カルボスチリル誘導体 |
| JPS61145162A (ja) | 1984-12-19 | 1986-07-02 | Otsuka Pharmaceut Co Ltd | カルボスチリル誘導体 |
| DE3701277A1 (de) * | 1987-01-17 | 1988-07-28 | Boehringer Mannheim Gmbh | Neue tricyclische benzimidazole, verfahren zu ihrer herstellung und verwendung als arzneimittel |
| JPH01319453A (ja) | 1988-06-22 | 1989-12-25 | Wakamoto Pharmaceut Co Ltd | 新規ベンゾキノン誘導体 |
| ATE355273T1 (de) | 2003-05-12 | 2006-03-15 | Pfizer Prod Inc | Benzamidinhibitoren des p2x7-rezeptors |
| US20050209247A1 (en) | 2003-11-07 | 2005-09-22 | Chiron Corporation | Pharmaceutically acceptable salts of quinolinone compounds having improved pharmaceutical properties |
| EP1718306A2 (en) | 2004-02-20 | 2006-11-08 | Chiron Corporation | Modulation of inflammatory and metastatic processes |
| JPWO2006132295A1 (ja) | 2005-06-09 | 2009-01-08 | 大日本住友製薬株式会社 | アルドステロン受容体調節剤 |
| JP2006349902A (ja) | 2005-06-15 | 2006-12-28 | Fujifilm Holdings Corp | 黒白熱現像感光材料 |
| WO2010102286A2 (en) | 2009-03-06 | 2010-09-10 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Proteasome inhibitors having chymotrypsin-like activity |
| US8541404B2 (en) * | 2009-11-09 | 2013-09-24 | Elexopharm Gmbh | Inhibitors of the human aldosterone synthase CYP11B2 |
| WO2013066469A2 (en) | 2011-08-15 | 2013-05-10 | Seattle Children's Research Institute | Kinase inhibitors capable of increasing the sensitivity of bacterial pathogens to b-lactam antibiotics |
| WO2013027168A1 (en) | 2011-08-22 | 2013-02-28 | Pfizer Inc. | Novel heterocyclic compounds as bromodomain inhibitors |
| WO2013170072A2 (en) * | 2012-05-09 | 2013-11-14 | Neurop, Inc. | Compounds for the treatment of neurological disorders |
| CA2926250A1 (en) | 2013-10-04 | 2015-04-09 | Bayer Cropscience Aktiengesellschaft | Use of substituted dihydro-oxindolyl sulfonamides, or the salts thereof, for increasing the stress tolerance of plants |
| WO2015092118A1 (en) | 2013-12-17 | 2015-06-25 | Orion Corporation | Spiro[cyclobutane-1,3'-indolin]-2'-one derivatives as bromodomain inhibitors |
| HUE051255T2 (hu) | 2014-02-19 | 2021-03-01 | Aviv Therapeutics Inc | Mitokondriális aldehid dehidrogenáz 2 (ALDH2) kötõ policiklusos amidok és alkalmazásuk rák kezelésére |
| EP3143009B1 (en) | 2014-05-12 | 2019-09-18 | Fondazione Istituto Italiano di Tecnologia | Substituted benzoxazolone derivatives as acid ceramidase inhibitors, and their use as medicaments |
| JP6759514B2 (ja) | 2014-08-01 | 2020-09-23 | ヌエヴォリューション・アクティーゼルスカブＮｕｅｖｏｌｕｔｉｏｎ Ａ／Ｓ | ブロモドメインに対して活性な化合物 |
| WO2018109650A1 (en) | 2016-12-14 | 2018-06-21 | Aurigene Discovery Technologies Limited | Spiro[cyclopentane-1,3'-indolin]-2'-one derivatives as bromodomain inhibitors |
| CN108690043B (zh) | 2017-04-11 | 2019-10-18 | 东莞东阳光科研发有限公司 | 喹啉类衍生物及其制备方法和用途 |
| CN112638881B (zh) | 2018-07-31 | 2025-01-07 | 普林斯顿大学托管委员会 | 用于治疗转移性和化疗耐受性癌症的四氢喹啉衍生物 |
| WO2021151062A1 (en) | 2020-01-24 | 2021-07-29 | The Trustees Of Princeton Univeristy | Heterocyclic compounds and uses thereof |
| GB202019475D0 (en) | 2020-12-10 | 2021-01-27 | Cancer Research Tech Ltd | Therapeutic compounds and their use |
| IL324964A (en) | 2021-04-22 | 2026-01-01 | Kayothera Inc | Modified heterocycles as aldehyde dehydrogenase inhibitors |
-
2022
- 2022-04-22 IL IL324964A patent/IL324964A/en unknown
- 2022-04-22 CA CA3213692A patent/CA3213692A1/en active Pending
- 2022-04-22 KR KR1020267003731A patent/KR20260022493A/ko active Pending
- 2022-04-22 AU AU2022262654A patent/AU2022262654A1/en active Pending
- 2022-04-22 CN CN202280042077.8A patent/CN117897370A/zh active Pending
- 2022-04-22 KR KR1020237039718A patent/KR102925139B1/ko active Active
- 2022-04-22 JP JP2023565154A patent/JP7781391B2/ja active Active
- 2022-04-22 IL IL307873A patent/IL307873B1/en unknown
- 2022-04-22 EP EP22792627.6A patent/EP4326696A4/en active Pending
- 2022-04-22 MX MX2023012435A patent/MX2023012435A/es unknown
- 2022-04-22 WO PCT/US2022/026059 patent/WO2022226383A1/en not_active Ceased
-
2023
- 2023-09-28 ZA ZA2023/09153A patent/ZA202309153B/en unknown
- 2023-10-17 US US18/488,924 patent/US12054475B2/en active Active
-
2024
- 2024-06-18 US US18/746,835 patent/US20240343709A1/en active Pending
-
2025
- 2025-11-17 JP JP2025196737A patent/JP2026020230A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024514709A5 (https=) | ||
| CN113365988A (zh) | Shp2抑制剂及其应用 | |
| JP7427098B2 (ja) | タンパク質キナ－ゼ阻害活性を有する７－アミノ－３，４－ジヒドロピリミドピリミジン－２－オン誘導体およびこれを含む治療用薬学組成物 | |
| JP2022547952A5 (https=) | ||
| JP2023507669A (ja) | ピリド［３，４－ｄ］ピリミジン誘導体およびこれを含む治療用薬学組成物 | |
| EP3008053B1 (en) | Phosphatidylinositol 3-kinase inhibitors | |
| JP2025023997A (ja) | Ｆａｋ阻害剤およびその併用薬物 | |
| IL311645B1 (en) | 2,5-Dimethomers of 3-methylpyrazines and 2,5,6-Trimethomers of 3-methylpyrazines as allosteric SHP2 inhibitors | |
| CN114430739A (zh) | Egfr抑制剂、组合物及其制备方法 | |
| JP7201260B2 (ja) | ピリジンアミン－ピリドンおよびピリミジンアミン－ピリドン化合物 | |
| JP2016514718A5 (https=) | ||
| JP2021504443A5 (https=) | ||
| CN107548391A (zh) | 嘧啶或吡啶类化合物、其制备方法和医药用途 | |
| JP2022544714A5 (https=) | ||
| JP2016522232A5 (https=) | ||
| CA2822565A1 (en) | Bi-heteroaryl compounds as vps34 inhibitors | |
| JP2016525076A5 (https=) | ||
| TW200413353A (en) | Azaarene derivatives | |
| JP2017535589A (ja) | ２−アミノピリミジン系化合物およびその薬物組成物と使用 | |
| IL292608A (en) | History of pyridine-2(1h)-one quinolinone as mutant dehydrogenase inhibitors-isocitrate | |
| AU2011251321A1 (en) | Nitrogen-containing heterocyclic compound having kynurenine production inhibitory activity | |
| TW202313048A (zh) | 組合療法 | |
| RU2018131775A (ru) | 6-арил-4-морфолин-1-илпиридоны, пригодные для лечения рака или диабета | |
| JP6979595B2 (ja) | プロテインキナーゼ阻害剤としてのアミノチアゾール化合物 | |
| JP2021514395A5 (https=) |